Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Oyaguez, I
  • Gomez-Peralta, F
  • Artola, S
  • Carrasco, FJ
  • Carretero-Gomez, J
  • Garcia-Soidan, J
  • Gomez-Huelgas, R
  • Perez, A

Grupos

Abstract

Introduction FreeStyle Libre(R) 2 system is a sensor-based flash-monitoring system that measures interstitial fluid glucose. The study aimed to compare cost of FreeStyle Libre 2 system and self-monitoring of blood glucose (SMBG) in the type 2 diabetes mellitus (T2DM) population from the Spanish Health System perspective. Methods On the basis of data collected from a literature review, the cost of glucose monitoring was modelled for patients with T2DM on a basal-bolus insulin regimen. The cost estimate included annual consumption for glucose monitoring (strips, lancets and sensors) and severe hypoglycaemic events (SHE) management. A published rate of SHE (2.5 episodes/patient-year) was considered. A reduction of SHE (- 48.8%) associated with FreeStyle Libre 2 system, derived from the REPLACE trial, was applied. Hospital attendance for 20.5% of SHEs (with subsequent hospitalization in 16.0%) was applied. Consumption of strips and lancets was set at 6/day for SMBG (derived from national monitoring recommendations), and 0.2/day for FreeStyle Libre 2 system users, with 26 FreeStyle Libre 2 sensors/year. Unitary costs (euro, year 2020 excluding VAT) were derived from literature (euro0.28/strip; euro0.09/lancet; euro3.09/daily FM sensor; euro3804/hospitalized SHE; euro1794/hospital-attended non-admitted SHE; euro389/community-attended SHE). Results Costs were euro2700 and euro2120/year/patient using SMBG or FreeStyle Libre 2 system, respectively. For 1000 patients with T2DM using basal-bolus insulin, 1220 SHEs/year (with 48 hospitalizations) could be prevented and FreeSytle Libre 2 system could generate cost savings of up to euro580,953/year versus SMBG (- 21.5%). Conclusion FreeStyle Libre 2 system is a potential cost-saving strategy in patients with T2DM in Spain on a basal-bolus insulin regimen.

Datos de la publicación

ISSN/ISSNe:
1869-6953, 1869-6961

Diabetes Therapy  SPRINGER HEIDELBERG

Tipo:
Article
Páginas:
2329-2342
PubMed:
33948909
Factor de Impacto:
0,902 SCImago ℠
Cuartil:
Q2 SCImago ℠

Citas Recibidas en Web of Science: 15

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Cost; Diabetes; Flash; FreeStyle Libre; Glucose monitoring

Cita

Compartir